AI drug discovery company

Aitia

Data as of Oct 17, 2026.

Company facts

Founded

2000

ReportedSource for founded (opens in new tab)
Headquarters

United States (Somerville, MA)

ReportedSource for headquarters (opens in new tab)
Total funding

about $65M to $77M

ReportedSource for total funding (opens in new tab)

Latest funding round

Round: Series D
Date: Jul 2019
Amount: $23M
Lead investor: Cigna Ventures

ConfirmedSource for the latest round (opens in new tab)

Drug discovery partners

2 pharma. Pharma here means a company with approved products and roughly $1B or more in annual revenue.

Ono Pharmaceutical Pharma

Collaboration and option, Sep 2, 2026

Terms not disclosed

ConfirmedSource for Ono Pharmaceutical (opens in new tab)
UCB Pharma

Causal AI collaboration, Mar 15, 2023

Terms not disclosed

ConfirmedSource for UCB (opens in new tab)

Recent news

Sep 3, 2026

Ono Pharma partnership on causal AI drug discovery

ReportedSource (opens in new tab)
Sep 2, 2026

Ono Pharmaceutical enters a drug discovery partnership with Aitia in neurological diseases

ConfirmedSource (opens in new tab)

Confirmed means the company, a partner or a filing said it. Reported means a third party said it. This section sits outside the Pharma AI Tracker.

Spot an error? Tell me and I'll fix it.